Stephen Morlock is Director at BioPharmX Corp (BPMX). They have made 8 open-market trades across 1 company since 2015, most recently 2018-10-22.
CIK 0001637670
7 open-market purchases totalling $244K since 2015, against 1 sale. Across 7 scored buys the stock is down 0.6% at ninety days, and 3.9 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BPMX | 434,857 | $2.7M |
Shares reported on the most recent Form 4, priced at the 2018-10-22 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 29% | 43% |
| Avg Move | +2.0% | +4.6% | -0.6% |
| Alpha | +4.0% | +5.5% | -3.9% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMX | SELL | 2018-10-18 | 2018-10-22 | $0.19 | $290K | -6.5% | -8.1% | -38.4% |
| BPMX | BUY | 2017-11-24 | 2017-11-27 | $0.15 | $50K | -10.6% | -7.8% | +43.3% |
| BPMX | BUY | 2016-11-28 | 2016-11-29 | $0.35 | $150K | +38.2% | +39.9% | +68.5% |
| BPMX | BUY | 2016-01-13 | 2016-01-15 | $1.52 | $18K | +6.1% | +8.8% | -42.2% |
| BPMX | BUY | 2016-01-11 | 2016-01-12 | $1.53 | $9K | -1.3% | -0.6% | -42.9% |
| BPMX | BUY | 2016-01-07 | 2016-01-11 | $1.47 | $7K | -5.8% | -5.2% | -48.6% |
| BPMX | BUY | 2015-10-14 | 2015-10-15 | $1.24 | $6K | -6.4% | -1.3% | -6.4% |
| BPMX | BUY | 2015-10-09 | 2015-10-13 | $1.21 | $4K | -6.4% | -1.3% | +24.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.